250th ACS National Meeting & Exposition

  • Author/Organiser: American Chemical Society (ACS)
  • Event Website: http://www.acs.org/content/acs/en/meetings/fall-2015.html
  • Event Date: 16 August 2015 to 20 August 2015
  • Event Type: Exhibition
  • Venue: Boston, Massachusetts, USA
  • Associated Societies: American Chemical Society (ACS), USA

View Full Event Details

Giving scientific professionals a platform to present, publish, discuss and exhibit the most exciting research discoveries and technologies in chemistry and its related disciplines. The meeting will facilitate networking opportunities, career development and placement, and provide companies an opportunity to exhibit products and services to a targeted audience.

The Exposition will give attendees the chance to meet more than 250 exhibitors, many of whom are showcasing new technological developments. A number of exhibitors also offer free workshops during the meeting so attendees can learn more about these state-of-the-art technologies.

Theme: Innovation from Discovery to Application



Session Chaired by Seth Cohen (UC San Diego) and Zachary Sweeney

Drugs, Drug Candidates, and New Targets at the Interface of Medicinal and Inorganic Chemistry

Metalloproteins represent an important therapeutic target class because of their involvement in a diverse range of biological processes, such as protein matrix degradation and gene regulation, implicated in human disease. There are numerous drugs in the clinic that address metalloproteins; examples include Captopril (ACE inhibitor used for the treatment of hypertension and heart failure), Vorinostat (HDAC inhibitor used to treat cutaneous T cell lymphoma), and Raltegravir (HIV integrase inhibitor). Given the success, it is unsurprising that metalloproteins have captured the imagination of the medicinal and bioinorganic chemistry communities.

ChemMedChem International Advisory Board member Seth Cohen (UC San Diego) and Zachary Sweeney (Denali Therapeutics) will be chairing a session at the 250th American Chemical Society National Meeting & Exposition (Boston, USA) entitled "Metalloprotein Inhibitors: Drugs, Drug Candidates, and New Targets at the Interface of Medicinal and Inorganic Chemistry". Among the speakers are ChemMedChem authors Christopher Schofield (University of Oxford), Abbas Walji (Merck Co Inc.), and of course, Seth Cohen.

The session will take place on Monday August 17th at 1:30 PM - 5:20 PM in Room 160C of the Boston Convention & Exhibition Center.

INOR: Metalloprotein Inhibitors: Drugs, Drug Candidates, and New Targets at the Interface of Medicinal and Inorganic Chemistry
Mon, Aug 17 at 1:30 PM - 5:20 PM
Organized and chaired by Seth Cohen and Zachary Sweeney

INOR 303: Design and optimization of potent, selective fungal CYP51 inhibitors
William Hoekstra (Viamet Pharmaceuticals) / 1:40pm - 2:15pm

INOR 304: Specificity and regulation of metal-dependent deacetylases: Implications for biological function
Carol Fierke (University of Michigan) / 2:15pm - 2:50pm

INOR 305: Structural studies on metal-binding pharmacophores for metalloprotein inhibitors
Seth Cohen (U.C. San Diego) / 2:50pm - 3:25pm

INOR 306: Novel inhibitors of iron and zinc-containing enzymes
Christopher Schofield (University of Oxford) / 3:35pm - 4:10pm

INOR 307: Drug discovery strategies toward a once daily HIV integrase strand transfer inhibitor
Abbas Walji (Merck Co Inc.) / 4:10pm - 4:45pm

INOR 308: Recent advances in the development of influenza endonuclease inhibitors
Joseph Bauman (Rutgers University) / 4:45pm - 5:20pm

Select ChemMedChem articles from these speakers

Discovery of MK-8970: an acetal carbonate prodrug of raltegravir with enhanced colonic absorption,
Walji AM, Sanchez RI, Clas SD, Nofsinger R, de Lera Ruiz M, Li J, Bennet A, John C, Bennett DJ, Sanders JM, Di Marco CN, Kim SH, Balsells J, Ceglia SS, Dang Q, Manser K, Nissley B, Wai JS, Hafey M, Wang J, Chessen G, Templeton A, Higgins J, Smith R, Wu Y, Grobler J, Coleman PJ.
ChemMedChem 2015, 10(2), 245–252. DOI: 10.1002/cmdc.201402393.

Chromophore-linked substrate (CLS405): probing metallo-β-lactamase activity and inhibition,
Makena A, van Berkel SS, Lejeune C, Owens RJ, Verma A, Salimraj R, Spencer J, Brem J, Schofield CJ.
ChemMedChem 2013, 8(12), 1923–1929. DOI: 10.1002/cmdc.201300350.

Chelator fragment libraries for targeting metalloproteinases,
Agrawal A, Johnson SL, Jacobsen JA, Miller MT, Chen LH, Pellecchia M, Cohen SM.
ChemMedChem 2010, 5(2), 195-9. DOI: 10.1002/cmdc.200900516.

Article Views: 11189

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH